Biolife Solutions (BLFS) Non Operating Investment Income (2020 - 2023)
Historic Non Operating Investment Income for Biolife Solutions (BLFS) over the last 4 years, with Q2 2024 value amounting to -$4.1 million.
- Biolife Solutions' Non Operating Investment Income changed N/A to -$4.1 million in Q2 2024 from the same period last year, while for Jun 2025 it was -$4.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of -$4.1 million for FY2024, which is N/A changed from last year.
- Per Biolife Solutions' latest filing, its Non Operating Investment Income stood at -$4.1 million for Q2 2024.
- Biolife Solutions' Non Operating Investment Income's 5-year high stood at $1.1 million during Q3 2020, with a 5-year trough of -$4.1 million in Q2 2024.
- Moreover, its 4-year median value for Non Operating Investment Income was $12500.0 (2020), whereas its average is -$442166.7.
- Over the last 5 years, Biolife Solutions' Non Operating Investment Income had its largest YoY gain of 12336.96% in 2023, and its largest YoY loss of 12336.96% in 2023.
- Biolife Solutions' Non Operating Investment Income (Quarter) stood at $209000.0 in 2020, then surged by 233.49% to $697000.0 in 2022, then plummeted by 158.97% to -$411000.0 in 2023, then plummeted by 891.24% to -$4.1 million in 2024.
- Its Non Operating Investment Income stands at -$4.1 million for Q2 2024, versus -$411000.0 for Q1 2023 and $697000.0 for Q3 2022.